Juan José Soler-Cataluña1, Luis Puente Maestu2, Miguel Román-Rodríguez3, Cristóbal Esteban4, Joaquín Gea5, Roberto Bernabeu Mora6, Eulogio Pleguezuelos Cobo7, Julio Ancochea8, Gema Monteagudo Ruiz9, Francisco Garcia Rio10. 1. Hospital Arnau de Vilanova, Valencia, España; CIBERES (ISCIII), Barcelona, España. Electronic address: jjsoler@telefonica.net. 2. Hospital Gregorio Marañón, Facultad de Medicina UCM, Madrid, España. 3. Centro de Salud Son Pisa, Atención Primaria; Instituto de Investigación Sanitaria de Baleares (IdISBa), Palma de Mallorca, España. 4. Hospital de Galdakao, Red de Investigación en Servicios Sanitarios y Enfermedades Crónicas (REDISSEC), Bilbao (Vizcaya), España. 5. CIBERES (ISCIII), Barcelona, España; Hospital del Mar, IMIM, DCEXS (UPF), Barcelona, España. 6. Hospital General Universitario Morales Meseguer, Murcia, España. 7. Hospital de Mataró, Mataró (Barcelona), España. 8. Hospital La Princesa, Instituto de Investigación Sanitaria Princesa (IP), Universidad Autónoma de Madrid, Madrid, España. 9. Astrazeneca S.A., Madrid, España. 10. Hospital La Paz, IdiPAZ y CIBERES (ISCIII), Madrid, España.
Abstract
INTRODUCTION: Physical activity (PA) is a significant clinical dimension in COPD, but no useful tools are available to determine this variable in routine clinical practice. OBJECTIVE: To create a simple, easy-to-use, specific questionnaire to detect PA deficits. METHOD: A multidisciplinary panel of COPD experts was formed to review PA, its determinants, and measuring methods. The methodology for selecting specific dimensions and items was agreed in rounds, and the aspects to be included in the preliminary version were determined. The questionnaire structure was defined according to applicability of these aspects in clinical practice. Agreements were reached by consensus of the members. RESULTS: A total of 148 items were reviewed, of which only 3 were directly selected. It was decided that the questionnaire should evaluate the intensity (low, moderate, or intense), amount, and frequency of PA, and inactivity or sedentary lifestyles. It also gathers information on the profile of inactive patients, and includes a measure of impact, defined as the patient's perception of their expectations regarding activity, their personal experience, characteristics of their environment, and their personality. The questionnaire is divided into 2blocks, one aimed at quantifying PA, and the other at collecting data for defining the profile and impact in patients with low PA only. CONCLUSION: The SAQ-COPD is a simple, short, specific questionnaire, designed to evaluate PA in COPD patients in clinical practice.
INTRODUCTION: Physical activity (PA) is a significant clinical dimension in COPD, but no useful tools are available to determine this variable in routine clinical practice. OBJECTIVE: To create a simple, easy-to-use, specific questionnaire to detect PA deficits. METHOD: A multidisciplinary panel of COPD experts was formed to review PA, its determinants, and measuring methods. The methodology for selecting specific dimensions and items was agreed in rounds, and the aspects to be included in the preliminary version were determined. The questionnaire structure was defined according to applicability of these aspects in clinical practice. Agreements were reached by consensus of the members. RESULTS: A total of 148 items were reviewed, of which only 3 were directly selected. It was decided that the questionnaire should evaluate the intensity (low, moderate, or intense), amount, and frequency of PA, and inactivity or sedentary lifestyles. It also gathers information on the profile of inactive patients, and includes a measure of impact, defined as the patient's perception of their expectations regarding activity, their personal experience, characteristics of their environment, and their personality. The questionnaire is divided into 2blocks, one aimed at quantifying PA, and the other at collecting data for defining the profile and impact in patients with low PA only. CONCLUSION: The SAQ-COPD is a simple, short, specific questionnaire, designed to evaluate PA in COPD patients in clinical practice.
Authors: María Abad-Arranz; Ana Moran-Rodríguez; Enrique Mascarós Balaguer; Carmen Quintana Velasco; Laura Abad Polo; Sara Núñez Palomo; Jaime Gonzálvez Rey; Ana María Fernández Vargas; Antonio Hidalgo Requena; Jose Manuel Helguera Quevedo; Marina García Pardo; Jose Luis Lopez-Campos Journal: Int J Chron Obstruct Pulmon Dis Date: 2019-06-06